US officially leaves World Health Organization
bbc - Trump ordered the withdrawal a year ago, accusing the UN agency of failing to adopt reforms and mishandling the pandemic.
AI Summary: The U.S. has officially completed its exit from the World Health Organization—a policy ordered over a year ago—while uncertainties remain regarding the full finalization timeline. This move marks a dramatic reorientation of America’s role in global health governance.
H.H.S. Reverses Decision to Cut $2 Billion for Mental Health and Addiction Services
Jan Hoffman / nytimes - A day after funding termination notices went out to more than 2,000 programs nationwide, the administration reversed itself and reinstated the money.
AI Summary: After sending termination notices that slashed billions in funding for thousands of substance abuse and mental health programs, the Trump administration abruptly backtracked. Critics blasted the move as a chaotic flip-flop that left vital services in limbo and fueled political outrage.
CMS proposes new price transparency rules
Madeline Ashley / beckershospitalreview - President Donald Trump’s administration proposed significant updates Dec. 19 to healthcare price transparency rules to help make costs more “clear, accurate and actionable for Americans.” The proposal, shared by CMS, in partnership with the labor and the …
AI Summary: The Trump administration has proposed significant updates to CMS’s price transparency regulations, aiming to make healthcare pricing data more accessible and actionable for patients and payers by enforcing clearer disclosures and enhanced oversight.
What Trump’s New Drug Pricing Deal Means for People With Obesity
Rebecca Robbins, Dani Blum and Margot Sanger-Katz / nytimes - The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.
AI Summary: In a bold move to tackle the obesity crisis, the Trump administration has brokered agreements with industry giants such as Eli Lilly and Novo Nordisk to slash weight-loss drug prices. The deals, promising reductions as steep as $149 a month, have sparked both applause and debate over the future of drug pricing in America.